Work

Cytokine Release Syndrome (CRS) Is Not Required for CAR-T Cell Efficacy in Aggressive Large B-NHL

Year: 2022

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood-2022-155886

Authors: Shakthi Bhaskar, Vivek Patel, David L. Porter, Stephen J. Schuster, Loretta J. Nastoupil, Miguel-Angel Perales, Ana Alarcon Tomas, Michael R. Bishop, Joseph P. McGuirk, Richard T. Maziarz, Andy Chen, Veronika Bachanova, Peter A. Riedell, Olalekan O. Oluwole

Institutions: Vanderbilt University Medical Center, Abramson Cancer Center, University of Pennsylvania, The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, Universidad de Murcia, University of Chicago, University of Kansas Medical Center, Oregon Health & Science University, OHSU Knight Cancer Institute, University of Minnesota

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310093706

FWCI:

Cites:

Cited by:

Related to: 10